Neuropeptide Receptor Group
The Neuropeptide receptor laboratory studies G protein-coupled receptors (GPCRs) which represent the most important class of biomolecules for pharmaceutical development, being targeted by ~30 per cent of current drugs.
Our studies on the structure and function of novel neuropeptide GPCRs will enable the development of new drugs to specifically target neurological and other diseases.
Our research at a glimpse
- Studies on G protein-coupled receptors; structure, function and drug development
- Targeting peptide G-protein coupled receptors (GPCRs) for novel drug development
- Structure-based drug design targeting G-protein-coupled receptors
- Drug discovery: investigation of signalling by GPCRS using novel cellular biosensors
- Viral-mediated modulation of neuropeptide GPCR function in brain
Brain health affects all Australians. You can support our research by making a donation or a bequest.